Výsledky vyhledávání

Bone health and glucocorticoid-containing lymphoma therapy - a review of risk factors and preventative measures

Autor: Toby A. Eyre, Paw Jensen, Stephen Booth, Tarec Christoffer El‐Galaly

Publikováno v: Eyre, T A, Jensen, P, Booth, S & El-Galaly, T C 2022, ' Bone health and glucocorticoid-containing lymphoma therapy-a review of risk factors and preventative measures ', British Journal of Haematology, vol. 198, no. 3, pp. 431-442 . https://doi.org/10.1111/bjh.18104

With survival outcomes ever improving for patients with a wide range of lymphoma histologies, the focus on reducing long-term complications of therapy has increased. Recently published, complimentary population and retrospective series have highlight

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d169994ce1ba8bd861d4a7a9a2c26a91
https://vbn.aau.dk/da/publications/d37406f2-405b-41cd-a410-a52ee1afd182

Zobrazit plný text záznamu

The Impact of Trial Eligibility Criteria on Outcomes in a Nationwide Cohort of Newly Diagnosed DLBCL Patients Treated with R-CHOP

Autor: Freja Tang Severinsen, Paw Jensen, Judit Jørgensen, Thomas Stauffer Larsen, Laura Mors Haunstrup, Rasmus Kuhr Jensen, Arushi Khurana, Michael Roost Clausen, Lasse Hjort Jakobsen, Christian Bjørn Poulsen, Matthew J. Maurer, Peter de Nully Brown, Tarec Christoffer El-Galaly

Publikováno v: Severinsen, F T, Mors Haunstrup, L, Kuhr Jensen, R, Maurer, M J, Khurana, A, Jensen, P, Jørgensen, J M, Larsen, T S, Roost Clausen, M, Poulsen, C B, Brown, P D N, El-Galaly, T C & Hjort Jakobsen, L 2021, ' The Impact of Trial Eligibility Criteria on Outcomes in a Nationwide Cohort of Newly Diagnosed DLBCL Patients Treated with R-CHOP ', Blood, vol. 138, no. Supplement 1, 53 . https://doi.org/10.1182/blood-2021-151100

Background: Generalizability of results from clinical trials with narrow in-/exclusion criteria are a concern as significant deviations in efficacy or toxicity may occur when treatments are used in populations of elderly and more comorbid patients. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe14eee91abab7bd4365874b8f0ed4a
https://portal.findresearcher.sdu.dk/da/publications/eacd1d33-cd3f-4072-a09b-5cf4d8e2a9d6

Zobrazit plný text záznamu

A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment

Autor: Paw Jensen, Lasse Hjort Jakobsen, Martin Bøgsted, Joachim Baech, Simon Lykkeboe, Marianne Tang Severinsen, Peter Vestergaard, Tarec Christoffer El-Galaly

Publikováno v: Jensen, P, Hjort Jakobsen, L, Bøgsted, M, Baech, J, Lykkeboe, S, Severinsen, M T, Vestergaard, P & El-Galaly, T C 2022, ' A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment ', Blood advances, vol. 6, no. 8, pp. 2549-2556 . https://doi.org/10.1182/bloodadvances.2021006330

Lymphoma patients often receive high glucocorticoid doses as part of standard therapy. Observational studies have shown a substantial risk of glucocorticoid-induced osteoporosis (GIO) with associated fractures. The aim of the SIESTA trial was to dete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc95555974347730cf2d9fdbffd447c7
https://pubmed.ncbi.nlm.nih.gov/35045567

Zobrazit plný text záznamu

Hematological cancer survivors' experiences of participating in a shared care follow-up-an exploratory interview study

Autor: Martin Bøgsted, Mette Grønkjær, Mia Sommer, Tarec Christoffer El-Galaly, Paw Jensen, Lone Frandsen

Publikováno v: Sommer, M, Frandsen, L, Jensen, P, Bøgsted, M, El-Galaly, T C & Grønkjær, M 2021, ' Hematological cancer survivors' experiences of participating in a shared care follow-up-an exploratory interview study ', Journal of Cancer Survivorship, vol. 15, no. 4, pp. 620-629 . https://doi.org/10.1007/s11764-020-00955-y

PURPOSE: The aim of the present study was to explore hematological cancer survivors' experiences of participating in a shared care follow-up based on alternating routine physician visits and nurse-led telephone consultations at the Department of Hema

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dda3922f3881b580eda0d6d007225ce
https://vbn.aau.dk/da/publications/50811f9b-974c-4d2a-9b65-5087f8643151

Zobrazit plný text záznamu

Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review

Autor: Hanne Due, Jakob Madsen, Niels Ejskjaer, Karen Dybkær, Paw Jensen, Marie Lindhard Madsen

Publikováno v: Cancer Chemotherapy and Pharmacology
Madsen, M L, Due, H, Ejskjær, N, Jensen, P, Madsen, J & Dybkær, K 2019, ' Aspects of vincristine-induced neuropathy in hematologic malignancies : a systematic review ', Cancer Chemotherapy and Pharmacology, vol. 84, no. 3, pp. 471–485 . https://doi.org/10.1007/s00280-019-03884-5

Purpose Vincristine is widely used as anticancer therapy for a variety of hematological malignancies. The treatment is limited by progressive vincristine-induced neuropathy, possibly including both peripheral sensory and motor nerves, autonomic nervo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b762cbfd274554693fd05c63ed8f61a
https://doi.org/10.1007/s00280-019-03884-5

Zobrazit plný text záznamu

Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system

Autor: Lars Holger Ehlers, Anne Stoffersen Rytter, Henrik Gregersen, Marlene Maria Nielsen, Martin Bøgsted, Karen Dybkær, Anne Stidsholt Roug, Marianne Tang Severinsen, Anne Sig Vestergaard, Lars Børty, Paw Jensen, Rasmus Froberg Brøndum, Tarec Christoffer El-Galaly, Charles Vesteghem

Publikováno v: Brøndum, R F, Vestergaard, A S, Børty, L, Vesteghem, C, Rytter, A S, Nielsen, M M, Severinsen, M T, Jensen, P, Gregersen, H, El-Galaly, T C, Dybkær, K, Ehlers, L H, Bøgsted, M & Roug, A S 2021, ' Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system ', Future Oncology, vol. 17, no. 25, pp. 3331-3341 . https://doi.org/10.2217/fon-2021-0189

Aim: To estimate current real-world costs of drugs and supportive care for the treatment of multiple myeloma in a tax-based health system. Methods: Forty-one patients were included from a personalized medicine study (2016–2019). Detailed informatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821e342c47a8b4267239e19094cb9f46
https://pubmed.ncbi.nlm.nih.gov/34156281

Zobrazit plný text záznamu

Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region

Autor: Mette Grønkjær, Marianne Tang Severinsen, Paw Jensen, Tarec Christoffer El-Galaly, Jakob Madsen, Søren Ramme Nielsen, Lars Børty Nielsen, Lone Frandsen, Martin Bøgsted, Rasmus Froberg Brøndum, Mia Sommer, Erik Elgaard Sørensen

Publikováno v: Sommer, M, Frandsen, L, Jensen, P, Nielsen, S R, Nielsen, L B, Brøndum, R F, Bøgsted, M, Madsen, J, Severinsen, M T, Sørensen, E E, Grønkjær, M & El-Galaly, T C 2020, ' Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region ', BMC Health Services Research, vol. 20, no. 1, 1047 . https://doi.org/10.1186/s12913-020-05899-8
BMC Health Services Research
BMC Health Services Research, Vol 20, Iss 1, Pp 1-10 (2020)

Background Patients with B-cell neoplasms in remission are monitored with regular physician visits at the hospital. The current standard follow-up procedure is not evidence-based or individualized to patient needs. To improve and individualize the fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604e396c43af5455f2c71298f8b3927f
https://doi.org/10.1186/s12913-020-05899-8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání